Global Fatty Liver Treatment Market Report 2024

Fatty Liver Treatment Global Market Report 2024 – By Treatment Type (Anti-Rejection Drugs Or Immunosuppressants, Chemotherapy Drugs, Targeted Therapy, Vaccines, Anti-Viral Drugs), By Disease Type (Hepatitis, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Other Diseases), By End User (Hospitals, Ambulatory Surgery Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Fatty Liver Treatment Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Fatty Liver Treatment Market Definition And Segments

Fatty liver disease is a condition in which fat builds up in the liver, causing various symptoms and complications. Fatty liver treatment refers to the multiple strategies, interventions, and actions to address and manage fatty liver disease.

The main types of fatty liver treatment are anti-rejection drugs or immunosuppressants, chemotherapy drugs, targeted therapy, vaccines, and anti-viral drugs. Anti-rejection drugs, also known as immunosuppressants, are a class of medications used to suppress or weaken the body's immune response. They are indicated for hepatitis, liver cancer, non-alcoholic fatty liver disease, and others and are used by hospitals, ambulatory surgery centers, and others.

The fatty liver treatment market covered in this report is segmented –

1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants, Chemotherapy Drugs, Targeted Therapy, Vaccines, Anti-Viral Drugs

2) By Disease Type: Hepatitis, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Other Diseases

3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users

The fatty liver treatment market size has grown strongly in recent years. It will grow from $22.17 billion in 2023 to $23.58 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to obesity epidemic, sedentary lifestyles, unhealthy diets, limited treatment options, awareness campaigns.

The fatty liver treatment market size is expected to see strong growth in the next few years. It will grow to $30.11 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increased disease prevalence, rising healthcare expenditure, growing diabetes and metabolic syndrome, innovation in therapeutics. Major trends in the forecast period include precision medicine approaches, lifestyle modification programs, targeted therapies for Nash, non-invasive monitoring tools, technological advancements.

Increase In Alcohol Consumption

The increase in alcohol consumption is expected to propel the growth of the fatty liver treatment market going forward. Alcohol consumption refers to consuming beverages containing alcohol, a psychoactive substance with depressant effects on the central nervous system. Alcohol consumption can worsen fatty liver disease and lead to more severe liver conditions, including alcoholic fatty liver disease (AFLD) and alcoholic hepatitis. For instance, in December 2022, according to a report published by Kirin Holdings Company Limited, a Japan-based beverages company, about 185.60 million kiloliters of beer were consumed worldwide in 2021, a rise of 4.0% from 2020. Therefore, the increase in alcohol consumption is driving the growth of the fatty liver treatment market.

High Prevalence Of Diabetes

High prevalence of diabetes is expected to propel the growth of the fatty liver treatment market going forward. The prevalence of diabetes refers to the proportion or percentage of the population that has been diagnosed with diabetes at a specific point in time. Diabetes is a significant risk factor for the development and progression of fatty liver disease, creating a substantial patient base. Individuals with diabetes often experience metabolic imbalances that contribute to the accumulation of fat in the liver. For instance, in April 2023, according to a report published by The British Diabetic Association, a UK-based diabetes charity, 4.3 million individuals in the UK have diabetes and live with it. Further, more than 2.4 million people in the UK are at high risk of acquiring type 2 diabetes, and registration numbers for 2021–22 are 148,951. Therefore, the high prevalence of diabetes is driving the growth of the fatty liver treatment market.

Major companies operating in the fatty liver treatment market report are Pfizer Inc., Johnson & Johnson Services Inc., Hoffmann La Roche Ltd., AstraZeneca PLC, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., The Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Mitsubishi Chemical Holdings, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Novo Nordisk A/S, Eisai Co. Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, GW Pharmaceuticals Limited, Retrophin Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., AbbKine Scientific Co. Ltd., Daewoong Co. Ltd., Madrigal Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Limited, Genfit, NGM Biopharmaceuticals Inc., Cardax Inc., Conatus Pharmaceuticals Inc., Limerick Biopharma Inc.

Pioneering Product Innovations To Transform The Market Landscape

Product innovation is a key trend gaining popularity in the fatty liver treatment market. Major companies operating in fatty liver treatment are developing innovative products to strengthen their position in the market. For instance, in March 2023, Akero Therapeutics, a US-based biotechnology company, reported positive Phase II reports of efruxifermin, indicated for the treatment of non-invasively diagnosed nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). It is a differentiated Fc-FGF21 fusion protein that mimics the biological activity of fibroblast growth factor 21 (FGF21), which regulates multiple metabolic pathways and cellular processes.

Torrent Pharmaceuticals And Zydus Lifesciences Join Forces To Advance Fatty Liver Treatment Market

Major companies operating in fatty liver treatment market are focused on forming strategic alliances to strengthen their position in the market. Strategic partnership are aimed at achieving mutual benefits and strengthening the position of the companies involved. For instance, in October 2023, Torrent Pharmaceuticals, an India based pharmaceutical company agreement with Zydus Lifesciences, India based pharmaceutical company to co-market a groundbreaking medication for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The collaborative effort aims to make Saroglitazar Mg more widely accessible throughout the nation. Under the terms of the agreement, Torrent Pharmaceuticals secures semi-exclusive rights to co-market the product in India, branding it as Vorxar.

Ipsen Bolsters Rare Disease Portfolio With Acquisition Of Albireo Pharma Inc

In March 2023, Ipsen, a France-based biopharmaceutical company, acquired Albireo Pharma Inc. for $952 million. The addition of Albireo significantly increased Ipsen's focus on rare illnesses with unique pipeline potential, promising therapies for uncommon cholestatic liver illnesses in children and adults, and scientific and commercial skills. The acquisition also expanded Ipsen's portfolio of rare diseases. Albireo Pharma Inc. is a US-based biotechnology company developing bile acid modulators that can be used to treat fatty liver disorders.

North America was the largest region in the fatty liver treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the fatty liver treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The fatty liver treatment market consists of revenues earned by entities by providing medical evaluation, medical diagnosis, healthcare provider consultations, nutritional guidance, medication management, ongoing monitoring, and weight management programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The fatty liver treatment market also includes sales of thiazolidinediones, vitamin E, metformin, statins, polyunsaturated fatty acids, angiotensin receptor blockers, and pentoxifylline, which are used in providing fatty liver treatment services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The fatty liver treatment market research report is one of a series of new reports from The Business Research Company that provides fatty liver treatment market statistics, including fatty liver treatment industry global market size, regional shares, competitors with a fatty liver treatment market share, detailed fatty liver treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the fatty liver treatment industry. This fatty liver treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Fatty Liver Treatment Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $23.58 billion
Revenue Forecast In 2033 $30.11 billion
Growth Rate CAGR of 6.3% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants, Chemotherapy Drugs, Targeted Therapy, Vaccines, Anti-Viral Drugs
2) By Disease Type: Hepatitis, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Other Diseases
3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Johnson & Johnson Services Inc.; Hoffmann La Roche Ltd.; AstraZeneca plc; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi S.A.; The Bristol-Myers Squibb Company; GlaxoSmithkline plc; Mitsubishi Chemical Holdings; Takeda Pharmaceutical Company Limited; Gilead Sciences Inc.; Novo Nordisk A/S; Eisai Co. Ltd.; Zydus Lifesciences Limited; Glenmark Pharmaceuticals Limited; GW Pharmaceuticals Limited; Retrophin Inc.; Alnylam Pharmaceuticals Inc.; Intercept Pharmaceuticals Inc.; AbbKine Scientific Co. Ltd.; Daewoong Co. Ltd.; Madrigal Pharmaceuticals Inc.; Orchid Chemicals & Pharmaceuticals Limited; Genfit; NGM Biopharmaceuticals Inc.; Cardax Inc.; Conatus Pharmaceuticals Inc.; Limerick Biopharma Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Fatty Liver Treatment Market Characteristics

    3. Fatty Liver Treatment Market Trends And Strategies

    4. Fatty Liver Treatment Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Fatty Liver Treatment Market Size and Growth

    5.1. Global Fatty Liver Treatment Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Fatty Liver Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Fatty Liver Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Fatty Liver Treatment Market Segmentation

    6.1. Global Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Anti-Rejection Drugs Or Immunosuppressants

    Chemotherapy Drugs

    Targeted Therapy

    Vaccines

    Anti-Viral Drugs

    6.2. Global Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hepatitis

    Liver Cancer

    Non-Alcoholic Fatty Liver Disease

    Other Diseases

    6.3. Global Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Ambulatory Surgery Centers

    Other End Users

    7. Fatty Liver Treatment Market Regional And Country Analysis

    7.1. Global Fatty Liver Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Fatty Liver Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Fatty Liver Treatment Market

    8.1. Asia-Pacific Fatty Liver Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Fatty Liver Treatment Market

    9.1. China Fatty Liver Treatment Market Overview

    9.2. China Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Fatty Liver Treatment Market

    10.1. India Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Fatty Liver Treatment Market

    11.1. Japan Fatty Liver Treatment Market Overview

    11.2. Japan Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Fatty Liver Treatment Market

    12.1. Australia Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Fatty Liver Treatment Market

    13.1. Indonesia Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Fatty Liver Treatment Market

    14.1. South Korea Fatty Liver Treatment Market Overview

    14.2. South Korea Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Fatty Liver Treatment Market

    15.1. Western Europe Fatty Liver Treatment Market Overview

    15.2. Western Europe Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Fatty Liver Treatment Market

    16.1. UK Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Fatty Liver Treatment Market

    17.1. Germany Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Fatty Liver Treatment Market

    18.5. France Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Fatty Liver Treatment Market

    19.9. Italy Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Fatty Liver Treatment Market

    20.13. Spain Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Fatty Liver Treatment Market

    21.1. Eastern Europe Fatty Liver Treatment Market Overview

    21.2. Eastern Europe Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Fatty Liver Treatment Market

    22.1. Russia Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Fatty Liver Treatment Market

    23.1. North America Fatty Liver Treatment Market Overview

    23.2. North America Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Fatty Liver Treatment Market

    24.1. USA Fatty Liver Treatment Market Overview

    24.2. USA Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Fatty Liver Treatment Market

    25.1. Canada Fatty Liver Treatment Market Overview

    25.2. Canada Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Fatty Liver Treatment Market

    26.1. South America Fatty Liver Treatment Market Overview

    26.2. South America Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Fatty Liver Treatment Market

    27.1. Brazil Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Fatty Liver Treatment Market

    28.1. Middle East Fatty Liver Treatment Market Overview

    28.2. Middle East Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Fatty Liver Treatment Market

    29.1. Africa Fatty Liver Treatment Market Overview

    29.2. Africa Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Fatty Liver Treatment Market Competitive Landscape And Company Profiles

    30.1. Fatty Liver Treatment Market Competitive Landscape

    30.2. Fatty Liver Treatment Market Company Profiles

    30.2.1. Prifzer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson Services Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Hoffmann La Roche Ltd.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. AstraZeneca plc

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Merck & Co. Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Fatty Liver Treatment Market Other Major And Innovative Companies

    31.1. AbbVie Inc.

    31.2. Bayer AG

    31.3. Novartis AG

    31.4. Sanofi S.A.

    31.5. The Bristol-Myers Squibb Company

    31.6. GlaxoSmithKline plc

    31.7. Mitsubishi Chemical Holdings

    31.8. Takeda Pharmaceutical Company Limited

    31.9. Gilead Sciences Inc.

    31.10. Novo Nordisk A/S

    31.11. Eisai Co. Ltd.

    31.12. Zydus Lifesciences Limited

    31.13. Glenmark Pharmaceuticals Limited

    31.14. GW Pharmaceuticals Limited

    31.15. Retrophin Inc.

    32. Global Fatty Liver Treatment Market Competitive Benchmarking

    33. Global Fatty Liver Treatment Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Fatty Liver Treatment Market

    35. Fatty Liver Treatment Market Future Outlook and Potential Analysis

    35.1 Fatty Liver Treatment Market In 2028 - Countries Offering Most New Opportunities

    35.2 Fatty Liver Treatment Market In 2028 - Segments Offering Most New Opportunities

    35.3 Fatty Liver Treatment Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Fatty Liver Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Fatty Liver Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Prifzer Inc. Financial Performance
  • Table 75: Johnson & Johnson Services Inc. Financial Performance
  • Table 76: Hoffmann La Roche Ltd. Financial Performance
  • Table 77: AstraZeneca plc Financial Performance
  • Table 78: Merck & Co. Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Fatty Liver Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Fatty Liver Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Prifzer Inc. Financial Performance
  • Figure 75: Johnson & Johnson Services Inc. Financial Performance
  • Figure 76: Hoffmann La Roche Ltd. Financial Performance
  • Figure 77: AstraZeneca plc Financial Performance
  • Figure 78: Merck & Co. Inc. Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Liver Cancer Diagnostics Global Market Report 2024 – By Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types), By Screening (Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies), By End Use (Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Liver Diseases Therapeutics Global Market Report 2024 – By Disease Type( Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer ), By Treatment( Antiviral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids ), By End User( Hospitals, Ambulatory Surgery Centers, Other End Users ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Fatty Amines Global Market Report 2024 – By Product (Primary Fatty Amines, Secondary Fatty Amines, Tertiary Fatty Amines), By Application (Agrochemicals Oilfield Chemicals, Asphalt Additives, Water Treatment, Chemical Synthesis, Personal Care, Household), By Function (Emulsifiers, Floatation Agents, Anti-Caking Agents, Dispersants, Corrosion Inhibitors, Chemical Intermediates) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Fatty Acids Global Market Report 2024 – By Product Type (Unsaturated Fatty Acids, Saturated Fatty Acids), By Form (Oil, Capsule, Syrup, Powder), By Source (Vegetable Oils, Marine, Nuts and Seeds, Soy and Soy Products, Animal Fat), By End User Industry (Household, Cosmetics, and Personal Care, Soap and Detergent, Oilfield, Rubber and Plastic, Lubricants, Other End-user Industries) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Inflammatory Bowel Disease Treatment Global Market Report 2024 – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Crohn's Disease, Ulcerative Colitis), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Non-Invasive Aesthetic Treatment Global Market Report 2024 – By Product (Injectable, Skin Rejuvenation), By End Use (Hospitals & Surgery Centers, Medical Spa, Clinics, Traditional Spa, HCP Owned Clinic) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Nasal Polyps Treatment Global Market Report 2024 – By Type (Pharmacological Therapies, Surgeries), By Route (Oral, Nasal, Other Routes ), By Distribution (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Chemical Surface Treatment Global Market Report 2024 – By Type (Cleaners, Plating Chemicals, Conversion Coatings, Other Types), By Base Material (Metals, Plastics, Other Base Materials), By Application (Metals Coloring, Corrosion Inhibitors, Post Treatment, Pretreatments Cleaners, Pretreatment Conditioners, Decorative, Planting, Other Applications), By End-User (Building And Construction, Transportation, Aerospace and Defense, Non-Ferrous Metal, Household Appliances) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the fatty liver treatment market?

Fatty liver disease is a condition in which fat builds up in the liver, causing various symptoms and complications. Fatty liver treatment refers to the multiple strategies, interventions, and actions to address and manage fatty liver disease. For further insights on the fatty liver treatment market, request a sample here

How will the fatty liver treatment market drivers and restraints affect the fatty liver treatment market dynamics? What forces will shape the fatty liver treatment industry going forward?

The fatty liver treatment market major growth driver - The Increase In Alcohol Consumption . For further insights on the fatty liver treatment market, request a sample here

What is the forecast market size or the forecast market value of the fatty liver treatment market?

The fatty liver treatment market size has grown strongly in recent years. It will grow from $22.17 billion in 2023 to $23.58 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to obesity epidemic, sedentary lifestyles, unhealthy diets, limited treatment options, awareness campaigns. The fatty liver treatment market size is expected to see strong growth in the next few years. It will grow to $30.11 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increased disease prevalence, rising healthcare expenditure, growing diabetes and metabolic syndrome, innovation in therapeutics. Major trends in the forecast period include precision medicine approaches, lifestyle modification programs, targeted therapies for nash, non-invasive monitoring tools, technological advancements. For further insights on the fatty liver treatment market, request a sample here

How is the fatty liver treatment market segmented?

The fatty liver treatment market is segmented
1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants, Chemotherapy Drugs, Targeted Therapy, Vaccines, Anti-Viral Drugs
2) By Disease Type: Hepatitis, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Other Diseases
3) By End User: Hospitals, Ambulatory Surgery Centers, Other End UsersFor further insights on the fatty liver treatment market, request a sample here

Which region has the largest share of the fatty liver treatment market? What are the other regions covered in the report?

North America was the largest region in the fatty liver treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the fatty liver treatment market, request a sample here.

Who are the major players in the fatty liver treatment market?

Major companies operating in the fatty liver treatment market report are Pfizer Inc., Johnson & Johnson Services Inc., Hoffmann La Roche Ltd., AstraZeneca plc, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., The Bristol-Myers Squibb Company, GlaxoSmithkline plc, Mitsubishi Chemical Holdings, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Novo Nordisk A/S, Eisai Co. Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, GW Pharmaceuticals Limited, Retrophin Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., AbbKine Scientific Co. Ltd., Daewoong Co. Ltd., Madrigal Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Limited, Genfit, NGM Biopharmaceuticals Inc., Cardax Inc., Conatus Pharmaceuticals Inc., Limerick Biopharma Inc. For further insights on the fatty liver treatment market, request a sample here.

What are the key trends in the fatty liver treatment market?

Major trend in the fatty liver treatment market - Pioneering Product Innovations To Transform The Market Landscape. For further insights on the fatty liver treatment market, request a sample here.

What are the major opportunities in the fatty liver treatment market? What are the strategies for the fatty liver treatment market?

For detailed insights on the major opportunities and strategies in the fatty liver treatment market, request a sample here.

How does the fatty liver treatment market relate to the overall economy and other similar markets?

For detailed insights on fatty liver treatment market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the fatty liver treatment industry?

For detailed insights on the mergers and acquisitions in the fatty liver treatment industry, request a sample here.

What are the key dynamics influencing the fatty liver treatment market growth? SWOT analysis of the fatty liver treatment market.

For detailed insights on the key dynamics influencing the fatty liver treatment market growth and SWOT analysis of the fatty liver treatment industry, request a sample here.